Search results

Showing 239 results

Patients Involved – DevelopAKUre for AKU

Patient Engagement

Introduction An example of public-private partnership from diverse international groups in industry (Sobi), patient organisations (AKU Society and ALCAP), hospitals (Royal Liverpool, Hospital Necker, and National Institute of Rheumatic...

Patients Involved – Patient medication labeling (USA)

Patient Engagement

Introduction Collaboration between patient advocates with academic institutions (Northwestern University and Emory University) and a pharmaceutical company Merck (Health Literacy and Healthcare Disparities Strategy group) to obtain a simplified...

Interview with Jan Geissler

Patient Engagement

Transcription My name is Jan Geissler. I’m a patient advocate now for fifteen years. I’ve been diagnosed with chronic myeloid leukemia in 2001. At that time, diagnosis really...

Why Patients’ Voices Matter – Documentary

Patient Engagement

Discover why patients’ voices matter by following David, Dimitrios, and Jan and how they have a voice in medicines R&D. How can EUPATI play a role to help patient...

Stratified versus personalised medicine

Medicines R&D

The term 'personalised medicine' includes both stratification and personalisation, which are often incorrectly used as synonyms. However, the two are different, as explained further below.

The role of statistics in clinical trials

Medicines R&D

The use of statistics in clinical trials is key in preventing errors and biases in research.

Making a medicine. Step 10: Life-cycle management

Medicines R&D

Life-cycle management activities begin as soon as a medicine receives authorisation from the regulatory authorities. Research on the medicine continues in order to gather additional data on safety and...

Enrolling in clinical trials

Medicines R&D

The process of enrolling in clinical trials is carefully regulated, as is the way in which sponsors advertise clinical trials to prospective participants. Patients are screened and must give...

Information on medicinal products

Medicines R&D

Information on medicinal products is provided to patients and healthcare providers in different, carefully regulated ways – including package labelling, package leaflets, and the Summary of Product Characteristics.

Patient involvement in EMA regulatory committees

Medicines R&D

This article explores patient involvement in scientific regulatory committees in the EU, specifically in the activities of the European Medicines Association (EMA).

...10...18 192021 22...

Filters

Sort by
- Medicines R&D
- Patient Engagement
Search the Toolbox

Resources on medicines research and development, including patient involvement in the medicines lifecycle

Tools and resources to enable meaningful patient involvement around and within medicines R&D

Find Out More

Toolbox

Guidance

Glossary

Creative Commons

Webinars